Page last updated: 2024-10-28

lidocaine and Heart Septal Defects, Ventricular

lidocaine has been researched along with Heart Septal Defects, Ventricular in 4 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research Excerpts

ExcerptRelevanceReference
"To investigate the influence of lidocaine on systemic inflammation in the perioperative ventricular septal defect (VSD)."9.11[Influence of lidocaine on systemic inflammation in perioperative patients undergoing cardiopulmonary bypass]. ( Chen, LB; Cheng, Y; Feang, G; Sun, CB; Zhang, WX, 2005)
"To investigate the influence of lidocaine on systemic inflammation in the perioperative ventricular septal defect (VSD)."5.11[Influence of lidocaine on systemic inflammation in perioperative patients undergoing cardiopulmonary bypass]. ( Chen, LB; Cheng, Y; Feang, G; Sun, CB; Zhang, WX, 2005)
"Pulmonary atresia witha ventricular septal defect and major aortopulmonary collateral arteries is an extremely rare congenital disorder characterized by a high risk of maternal mortality."1.48Anesthetic management for cesarean delivery in a patient with uncorrected pulmonary atresia, ventricular septal defect and major aortopulmonary collateral arteries. ( Chen, DD; Fang, KY; Gang, SP; Liu, XL; Ma, XW; Ma, Y; Wang, RP; Xiang, DK; Zhang, FX, 2018)
"Lidocaine (1."1.28Pharmacokinetics of lidocaine in children with congenital heart disease. ( Burrows, FA; LeDez, KM; Lerman, J; Strong, HA, 1991)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gang, SP1
Fang, KY1
Ma, Y1
Zhang, FX1
Xiang, DK1
Liu, XL1
Wang, RP1
Chen, DD1
Ma, XW1
Sun, CB1
Chen, LB1
Cheng, Y1
Feang, G1
Zhang, WX1
Burrows, FA1
Lerman, J1
LeDez, KM1
Strong, HA1
Dhurandhar, RW1
Teasdale, SJ1
Mahon, WA1

Trials

1 trial available for lidocaine and Heart Septal Defects, Ventricular

ArticleYear
[Influence of lidocaine on systemic inflammation in perioperative patients undergoing cardiopulmonary bypass].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2005, Dec-18, Volume: 37, Issue:6

    Topics: Adolescent; Cardiopulmonary Bypass; Child; Female; Heart Septal Defects, Ventricular; Humans; Inflam

2005

Other Studies

3 other studies available for lidocaine and Heart Septal Defects, Ventricular

ArticleYear
Anesthetic management for cesarean delivery in a patient with uncorrected pulmonary atresia, ventricular septal defect and major aortopulmonary collateral arteries.
    International journal of obstetric anesthesia, 2018, Volume: 36

    Topics: Adult; Anesthesia, Obstetrical; Anesthetics, Local; Aorta; Cesarean Section; Female; Heart Septal De

2018
Pharmacokinetics of lidocaine in children with congenital heart disease.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1991, Volume: 38, Issue:2

    Topics: Child, Preschool; Heart Septal Defects, Atrial; Heart Septal Defects, Ventricular; Humans; Infant; I

1991
Bretylium tosylate in the management of refractory ventricular fibrillation.
    Canadian Medical Association journal, 1971, Jul-24, Volume: 105, Issue:2

    Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl

1971
chemdatabank.com